Italian Resalis Therapeutics Srl has baged €10m in a Series A financing led by Sunstone Life Science Ventures to complete a Phase I study for RES-010 in obesity.
https://european-biotechnology.com/wp-content/uploads/2024/04/fat_cells_brown_white.png10861620Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-01-04 13:33:002024-07-09 12:30:45miRNA specialist Resalis Therapeutics Srl raises €10m in Series A financing